Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential (Q34719338)

4 August 2017

1 reference

title

Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential (English)

1 reference

4 August 2017

1 reference

Holliday SM

1

1 reference

PubMed ID

7506653

4 August 2017

Faulds D

series ordinal

2

1 reference

4 August 2017

1 October 1993

1 reference

4 August 2017

1 reference

4 August 2017

46

1 reference

4 August 2017

720-745

1 reference

4 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199346040-00008

4 August 2017

0 references

cites work

Activities of human alveolar macrophages (HAMs). Note 1: Observations on phagocytosis and bacterial killing in the presence of miocamycin

1 reference

12 December 2020

[Laboratory and clinical studies of 9,3"-diacetylmidecamycin in the pediatric field]

1 reference

12 December 2020

Some features of miocamycin in the gynecological field: pharmacokinetic data using preoperative administration and therapeutic aspects against chlamydial infections.

1 reference

12 December 2020

Miokamycin penetration into oral cavity tissues and crevicular fluid

1 reference

12 December 2020

Therapeutic activity and pharmacokinetic behavior of miokamycin in the respiratory system

1 reference

12 December 2020

Clinical efficacy of dirithromycin versus miocamycin in tonsillopharyngitis

1 reference

12 December 2020

In vitro Susceptibility of <i>Ureaplasma urealyticum </i>Clinical Isolates to New Macrolides

1 reference

12 December 2020

Clinical results of 9,3"-diacetylmidecamycin in the field of pediatrics (author's transl)

1 reference

12 December 2020

Use of miocamycin in the acute exacerbation of chronic obstructive bronchopneumopathy. Case material contribution

1 reference

12 December 2020

Pharmacokinetic drug interactions of macrolides

1 reference

12 December 2020

Efficacy of miocamycin in the therapy of non-specific genital infections (NSGI): non-gonococcal urethritis (NGU) and acute urethral syndrome (AUS).

1 reference

12 December 2020

Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria

1 reference

12 December 2020

Some pharmacokinetic data on miocamycin. I: Serum, urinary and prostatic levels.

1 reference

12 December 2020

Bacteriological evaluation of midecamycin acetate and its metabolites.

1 reference

12 December 2020

From foreign pharmacopoeias: 'new' antibiotics from old?

1 reference

12 December 2020

Streptococcal pharyngitis in Italian children: epidemiology and treatment with miocamycin

1 reference

12 December 2020

Miocamycin distribution in tonsillar and pulmonary tissues after repeated administration

1 reference

12 December 2020

In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci

1 reference

12 December 2020

Comparative in vitro potencies of nine new macrolides.

1 reference

12 December 2020

Clinical and microbiological effects of in vivo miocamycin therapy on oral infections and in surgical prophylaxis

1 reference

12 December 2020

Anti-mycoplasmal activity of a new macrolide: miocamycin

1 reference

12 December 2020

Clinical studies on 9, 3"-diacetylmidecamycin in respiratory tract infections in the field of pediatrics (author's transl)

1 reference

12 December 2020

In-vitro evaluation of miokamycin: bactericidal activity against streptococci

1 reference

12 December 2020

Clinical efficacy of dirithromycin versus miocamycin in the treatment of acute bronchitis or acute exacerbations of chronic bronchitis

1 reference

12 December 2020

Clinical and microbiological evaluation of miocamycin activity against group A beta-hemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci

1 reference

12 December 2020

Miocamycin doesn't affect theophylline serum levels in COPD patients.

1 reference

12 December 2020

Miocamycin in chlamydia trachomatis infections in neonatology: clinical results, pharmacokinetics and microbiological evaluation.

1 reference

12 December 2020

In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuclear leukocytes.

1 reference

12 December 2020

Effects of macrolides on ultrastructure of Staphylococcus aureus during postantibiotic phase

1 reference

12 December 2020

Post-antibiotic effects of miocamycin, roxithromycin and erythromycin on Gram-positive cocci.

1 reference

12 December 2020

Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy

1 reference

12 December 2020

Effect of ponsinomycin on cyclosporin pharmacokinetics

1 reference

12 December 2020

Anti-infectious prophylaxis in patients at risk for endocarditis in the treatment of the oral cavity. Importance of the antibiotic combination

1 reference

12 December 2020

Kinetic profile of miocamycin in middle ear fluid and mucosa

1 reference

12 December 2020

Effect of ponsinomycin on single-dose kinetics and metabolism of carbamazepine

1 reference

12 December 2020

Effects of macrolide antibiotics on gastrointestinal motility in fasting and digestive states

1 reference

12 December 2020

Prostatic tissue concentrations and serum levels of Myocamicin in human subjects

1 reference

12 December 2020

Some pharmacokinetic data on miocamycin II. Concentrations in gynaecological tissues

1 reference

12 December 2020

Pharmacokinetics of miocamycin in patients with liver cirrhosis

1 reference

12 December 2020

[Double-blind comparative study of roxithromycin (RU 28965) and midecamycin acetate (MOM) in the treatment of pneumonia]

1 reference

12 December 2020

[Clinical study of a new macrolide, miocamycin, in 150 patients with otorhinolaryngologic disorders]

1 reference

12 December 2020

Comparison of miocamycin versus amoxycillin in lower respiratory tract infections in children. Clinical response and effect on natural killer activity

1 reference

12 December 2020

[Annual changes in susceptibility of clinical isolates to midecamycin acetate].

1 reference

12 December 2020

Miocamycin and theophylline blood levels

1 reference

12 December 2020

Metabolism of 9,3"-diacetylmidecamycin. II. The structures of several metabolites of 9,3"-diacetylmidecamycin

1 reference

12 December 2020

Clinical studies of 9, 3"-diacetylmidecamycin (author's transl)

1 reference

12 December 2020

Lack of effect of ponsinomycin on the pharmacokinetics of nicoumalone enantiomers

1 reference

12 December 2020

In vitro and in vivo antibacterial activity of 9,3"-Di-o-acetyl midecamycin (Mom), a new macrolide antibiotic

1 reference

12 December 2020

Studies on 9,3"-diacetylmidecamycin dry syrup in pediatric acute respiratory tract infections (author's transl)

1 reference

12 December 2020

The New Macrolide Antibiotics: Azithromycin, Clarithromycin, Dirithromycin, and Roxithromycin

1 reference

12 December 2020

[Influence of food intake on the bioavailability of ponsinomycin administered in a syrup form]

1 reference

12 December 2020

Antibiotic entry into human polymorphonuclear leukocytes

1 reference

12 December 2020

The activity of miokamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitro

1 reference

12 December 2020

New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy

1 reference

12 December 2020

Intraphagocytic penetration of macrolides: in-vivo comparison of erythromycin and spiramycin

1 reference

12 December 2020

Laboratory and clinical studies of 9,3"-diacetylmidecamycin in the pediatric field

1 reference

12 December 2020

Clinical experience with miocamycin in the treatment of respiratory tract infections

1 reference

12 December 2020

Gastrointestinal motor effects of erythromycin

1 reference

12 December 2020

Clinical studies on 9,3"-diacetylmidecamycin in respiratory tract infections in pediatric field (author's transl)

1 reference

12 December 2020

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

1 reference

12 December 2020

Clinical study on 9,3"-diacetylmidecamycin in the field of pediatrics (author's transl)

1 reference

12 December 2020

Comparative efficacy and tolerance of erythromycin and josamycin in the prevention of bacteraemia following dental extraction

1 reference

12 December 2020

Miocamycin in the prevention and treatment of cutaneous infections in the emergency service

1 reference

12 December 2020

Comparative study on effects of 14- and 16-membered macrolides on gastrointestinal motility in unanaesthetized dogs

1 reference

12 December 2020

Effects of erythromycin on gastrointestinal tract motility.

1 reference

12 December 2020

Effect of miocamycin on theophylline kinetics in children

1 reference

12 December 2020

The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.

1 reference

12 December 2020

Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I).

1 reference

12 December 2020

A survey of the side effects of midecamycin acetate (Miocamycin) dry syrup after marketing

1 reference

12 December 2020

Effects of miocamycin and erythromycin on polymorphonuclear cell function

1 reference

12 December 2020

Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time

1 reference

12 December 2020

Comparison of the effects of midecamycin acetate and clarithromycin on gastrointestinal motility in man

1 reference

12 December 2020

Comparative in vitro activity of clarithromycin. Spanish Collaborative Group

1 reference

12 December 2020

Gastrointestinal motor effects of erythromycin in humans.

1 reference

12 December 2020

Miokamycin and leukocyte activity in man

1 reference

12 December 2020

Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses

1 reference

12 December 2020

Multiple mechanisms of erythromycin resistance.

1 reference

12 December 2020

Kinetics of erythromycin uptake and release by human lymphocytes and polymorphonuclear leucocytes

1 reference

12 December 2020

Influence of macrolide antibiotics on the chemiluminescence of zymosan-activated human neutrophils

1 reference

12 December 2020

Lack of effect of ponsinomycin on the plasma pharmacokinetics of theophylline

1 reference

12 December 2020

Clinical and bacteriological evaluation of miocamycin in some respiratory tract infections

1 reference

12 December 2020

In vitro antibacterial activity of macrolides and other antibiotics against anaerobic bacteria

1 reference

12 December 2020

Antibiotics as biological response modifiers

1 reference

12 December 2020

Fundamental and clinical evaluation of 9,3"-diacetylmidecamycin in pediatric field (author's transl)

1 reference

12 December 2020

[Pharmacokinetics of ponsinomycine with repeated ingestion in healthy volunteers]

1 reference

12 December 2020

Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

[Pharmacokinetics of ponsinomycin administered in a syrup form in single 400-800 and 1200 mg doses in healthy volunteers]

1 reference

12 December 2020

Effect of midecamycin acetate on gastrointestinal motility in humans

1 reference

12 December 2020

In-vitro postantibiotic effects of miocamycin and erythromycin on gram-positive cocci

1 reference

12 December 2020

Role of Chlamydia trachomatis in chronic prostatitis: diagnostic investigation and therapeutic experience with miocamycin.

1 reference

12 December 2020

[Clinical studies of 9,3"-diacetylmidecamycin in pediatric field (author's transl)]

1 reference

12 December 2020

In vitro activity of macrolides on human phagocytic functions

1 reference

12 December 2020

Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones.

1 reference

12 December 2020

10.2165/00003495-199346040-00008

Identifiers

DOI

1 reference

PubMed ID

7506653

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

7506653